Plougmann Vingtoft Blocks Inventors' Chemo Response IP
IP consulting firm Plougmann Vingtoft has convinced European appellate officials to nix a group of inventors' patented method to determine if a cancer patient is responsive to chemotherapy. ...To view the full article, register now.
Already a subscriber? Click here to view full article